 | • レポートコード：20QY06-02793 • 出版社/出版日：QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、148ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、パクリタキセルのグローバル市場について種類別（天然パクリタキセルAPI、半合成パクリタキセルAPI）、用途別（卵巣癌、子宮頸癌、乳癌、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・パクリタキセル市場の概要 ・世界の主要地域別パクリタキセル市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のパクリタキセル市場規模2015-2026：種類別（天然パクリタキセルAPI、半合成パクリタキセルAPI） ・世界のパクリタキセル市場規模2015-2026：用途別（卵巣癌、子宮頸癌、乳癌、その他） ・パクリタキセルの北米市場規模2015-2020 ・パクリタキセルのヨーロッパ市場規模2015-2020 ・パクリタキセルの中国市場規模2015-2020 ・パクリタキセルの日本市場規模2015-2020 ・パクリタキセルの東南アジア市場規模2015-2020 ・パクリタキセルのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Phyton、ScinoPharm、Novasep、Samyang、Polymed、TAPI (Teva)、Fresenius-kabi、Huiang biopharma、Southpharma、Yunnan Hande、Hainan Yew Pharm、Jiangsu Yew Biotechnology） ・パクリタキセルの製造コスト分析 ・販売チャネル、流通業者、顧客 ・パクリタキセルの市場動向・機会・課題 ・調査の結論 |
Paclitaxel is a mitotic inhibitor used in Cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew, Taxus brevifolia, and named it “taxol”.
In the last several years, global market of Paclitaxel developed rapidly, with an average growth rate of 12.3%. In 2017, global revenue of Paclitaxel is nearly 80 M USD; the actual production is about 2600 Kg.
Market Analysis and Insights: Global Paclitaxel Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Paclitaxel market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Paclitaxel industry.
Based on our recent survey, we have several different scenarios about the Paclitaxel YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 107.3 million in 2019. The market size of Paclitaxel will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Global Paclitaxel Scope and Market Size
The global Paclitaxel market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Paclitaxel market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Paclitaxel market is segmented into
Natural Paclitaxel API
Semi-synthetic Paclitaxel API
Segment by Application, the Paclitaxel market is segmented into
Ovarian Cancer
Cervical Cancer
Breast Cancer
Other
The Paclitaxel market is analysed and market size information is provided by regions (countries). Segment by Application, the Paclitaxel market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Paclitaxel Market Share Analysis
Paclitaxel market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Paclitaxel business, the date to enter into the Paclitaxel market, Paclitaxel product introduction, recent developments, etc.
The major vendors covered:
Phyton
ScinoPharm
Novasep
Samyang
Polymed
TAPI (Teva)
Fresenius-kabi
Huiang biopharma
Southpharma
Yunnan Hande
Hainan Yew Pharm
Jiangsu Yew Biotechnology
1 Paclitaxel Market Overview
1.1 Paclitaxel Product Scope
1.2 Paclitaxel Segment by Type
1.2.1 Global Paclitaxel Sales by Type (2020-2026)
1.2.2 Natural Paclitaxel API
1.2.3 Semi-synthetic Paclitaxel API
1.3 Paclitaxel Segment by Application
1.3.1 Global Paclitaxel Sales Comparison by Application (2020-2026)
1.3.2 Ovarian Cancer
1.3.3 Cervical Cancer
1.3.4 Breast Cancer
1.3.5 Other
1.4 Paclitaxel Market Estimates and Forecasts (2015-2026)
1.4.1 Global Paclitaxel Sales Growth Rate (2015-2026)
1.4.2 Global Paclitaxel Revenue and Growth Rate (2015-2026)
1.4.3 Global Paclitaxel Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Paclitaxel Industry Impact
1.5.1 How the Covid-19 is Affecting the Paclitaxel Industry
1.5.1.1 Paclitaxel Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Paclitaxel Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Paclitaxel Players to Combat Covid-19 Impact
2 Paclitaxel Estimate and Forecast by Region
2.1 Global Paclitaxel Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Paclitaxel Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Paclitaxel Sales Market Share by Region (2015-2020)
2.2.2 Global Paclitaxel Revenue Market Share by Region (2015-2020)
2.3 Global Paclitaxel Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Paclitaxel Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Paclitaxel Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Paclitaxel Estimates and Projections (2015-2026)
2.4.2 Europe Paclitaxel Estimates and Projections (2015-2026)
2.4.3 China Paclitaxel Estimates and Projections (2015-2026)
2.4.4 Japan Paclitaxel Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Paclitaxel Estimates and Projections (2015-2026)
2.4.6 India Paclitaxel Estimates and Projections (2015-2026)
3 Global Paclitaxel Competition Landscape by Players
3.1 Global Top Paclitaxel Players by Sales (2015-2020)
3.2 Global Top Paclitaxel Players by Revenue (2015-2020)
3.3 Global Paclitaxel Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Paclitaxel as of 2019)
3.4 Global Paclitaxel Average Price by Company (2015-2020)
3.5 Manufacturers Paclitaxel Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Paclitaxel Players (Opinion Leaders)
4 Global Paclitaxel Market Size by Type
4.1 Global Paclitaxel Historic Market Review by Type (2015-2020)
4.1.1 Global Paclitaxel Sales Market Share by Type (2015-2020)
4.1.2 Global Paclitaxel Revenue Market Share by Type (2015-2020)
4.1.3 Global Paclitaxel Price by Type (2014-2020)
4.2 Global Paclitaxel Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Paclitaxel Sales Forecast by Type (2021-2026)
4.2.2 Global Paclitaxel Revenue Forecast by Type (2021-2026)
4.2.3 Global Paclitaxel Price Forecast by Type (2021-2026)
5 Global Paclitaxel Market Size by Application
5.1 Global Paclitaxel Historic Market Review by Application (2015-2020)
5.1.1 Global Paclitaxel Sales Market Share by Application (2015-2020)
5.1.2 Global Paclitaxel Revenue Market Share by Application (2015-2020)
5.1.3 Global Paclitaxel Price by Application (2015-2020)
5.2 Global Paclitaxel Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Paclitaxel Sales Forecast by Application (2021-2026)
5.2.2 Global Paclitaxel Revenue Forecast by Application (2021-2026)
5.2.3 Global Paclitaxel Price Forecast by Application (2021-2026)
3 North America Paclitaxel Market Facts & Figures
3.2 North America Paclitaxel Sales Market Share by Company (2015-2020)
3.3 North America Paclitaxel Sales Market Share by Type (2015-2020)
3.4 North America Paclitaxel Sales Market Share by Application (2015-2020)
4 Europe Paclitaxel Market Facts & Figures
4.2 Europe Paclitaxel Sales Market Share by Company (2015-2020)
4.3 Europe Paclitaxel Sales Market Share by Type (2015-2020)
4.4 Europe Paclitaxel Sales Market Share by Application (2015-2020)
5 China Paclitaxel Market Facts & Figures
5.2 China Paclitaxel Sales Market Share by Company (2015-2020)
5.3 China Paclitaxel Sales Market Share by Type (2015-2020)
5.4 China Paclitaxel Sales Market Share by Application (2015-2020)
6 Japan Paclitaxel Market Facts & Figures
6.2 Japan Paclitaxel Sales Market Share by Company (2015-2020)
6.3 Japan Paclitaxel Sales Market Share by Type (2015-2020)
6.4 Japan Paclitaxel Sales Market Share by Application (2015-2020)
7 Southeast Asia Paclitaxel Market Facts & Figures
7.2 Southeast Asia Paclitaxel Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Paclitaxel Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Paclitaxel Sales Market Share by Application (2015-2020)
8 India Paclitaxel Market Facts & Figures
8.2 India Paclitaxel Sales Market Share by Company (2015-2020)
8.3 India Paclitaxel Sales Market Share by Type (2015-2020)
8.4 India Paclitaxel Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Paclitaxel Business
12.1 Phyton
12.1.1 Phyton Paclitaxel Corporation Information
12.1.2 Phyton Paclitaxel Business Overview and Total Revenue
12.1.3 Phyton Paclitaxel Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Phyton Paclitaxel Products Offered
12.1.5 Phyton Recent Development
12.2 ScinoPharm
12.2.1 ScinoPharm Paclitaxel Corporation Information
12.2.2 ScinoPharm Paclitaxel Business Overview and Total Revenue
12.2.3 ScinoPharm Paclitaxel Sales, Revenue and Gross Margin (2015-2020)
12.2.4 ScinoPharm Paclitaxel Products Offered
12.2.5 ScinoPharm Recent Development
12.3 Novasep
12.3.1 Novasep Paclitaxel Corporation Information
12.3.2 Novasep Paclitaxel Business Overview and Total Revenue
12.3.3 Novasep Paclitaxel Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Novasep Paclitaxel Products Offered
12.3.5 Novasep Recent Development
12.4 Samyang
12.4.1 Samyang Paclitaxel Corporation Information
12.4.2 Samyang Paclitaxel Business Overview and Total Revenue
12.4.3 Samyang Paclitaxel Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Samyang Paclitaxel Products Offered
12.4.5 Samyang Recent Development
12.5 Polymed
12.5.1 Polymed Paclitaxel Corporation Information
12.5.2 Polymed Paclitaxel Business Overview and Total Revenue
12.5.3 Polymed Paclitaxel Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Polymed Paclitaxel Products Offered
12.5.5 Polymed Recent Development
12.6 TAPI (Teva)
12.6.1 TAPI (Teva) Paclitaxel Corporation Information
12.6.2 TAPI (Teva) Paclitaxel Business Overview and Total Revenue
12.6.3 TAPI (Teva) Paclitaxel Sales, Revenue and Gross Margin (2015-2020)
12.6.4 TAPI (Teva) Paclitaxel Products Offered
12.6.5 TAPI (Teva) Recent Development
12.7 Fresenius-kabi
12.7.1 Fresenius-kabi Paclitaxel Corporation Information
12.7.2 Fresenius-kabi Paclitaxel Business Overview and Total Revenue
12.7.3 Fresenius-kabi Paclitaxel Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Fresenius-kabi Paclitaxel Products Offered
12.7.5 Fresenius-kabi Recent Development
12.8 Huiang biopharma
12.8.1 Huiang biopharma Paclitaxel Corporation Information
12.8.2 Huiang biopharma Paclitaxel Business Overview and Total Revenue
12.8.3 Huiang biopharma Paclitaxel Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Huiang biopharma Paclitaxel Products Offered
12.8.5 Huiang biopharma Recent Development
12.9 Southpharma
12.9.1 Southpharma Paclitaxel Corporation Information
12.9.2 Southpharma Paclitaxel Business Overview and Total Revenue
12.9.3 Southpharma Paclitaxel Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Southpharma Paclitaxel Products Offered
12.9.5 Southpharma Recent Development
12.10 Yunnan Hande
12.10.1 Yunnan Hande Paclitaxel Corporation Information
12.10.2 Yunnan Hande Paclitaxel Business Overview and Total Revenue
12.10.3 Yunnan Hande Paclitaxel Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Yunnan Hande Paclitaxel Products Offered
12.10.5 Yunnan Hande Recent Development
12.11 Hainan Yew Pharm
12.11.1 Hainan Yew Pharm Paclitaxel Corporation Information
12.11.2 Hainan Yew Pharm Paclitaxel Business Overview and Total Revenue
12.11.3 Hainan Yew Pharm Paclitaxel Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Hainan Yew Pharm Paclitaxel Products Offered
12.11.5 Hainan Yew Pharm Recent Development
12.12 Jiangsu Yew Biotechnology
12.12.1 Jiangsu Yew Biotechnology Paclitaxel Corporation Information
12.12.2 Jiangsu Yew Biotechnology Paclitaxel Business Overview and Total Revenue
12.12.3 Jiangsu Yew Biotechnology Paclitaxel Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Jiangsu Yew Biotechnology Paclitaxel Products Offered
12.12.5 Jiangsu Yew Biotechnology Recent Development
13 Paclitaxel Manufacturing Cost Analysis
13.1 Paclitaxel Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Paclitaxel
13.4 Paclitaxel Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Paclitaxel Distributors List
14.3 Paclitaxel Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Paclitaxel Sales (Kg) Growth Rate by Type (2020-2026)
Table 2. Global Paclitaxel Sales (Kg) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Paclitaxel Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Paclitaxel Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Paclitaxel Players to Combat Covid-19 Impact
Table 8. Global Market Paclitaxel Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Paclitaxel Sales (Kg) by Region (2015-2020)
Table 10. Global Paclitaxel Sales Market Share by Region (2015-2020)
Table 11. Global Paclitaxel Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Paclitaxel Revenue Share by Region (2015-2020)
Table 13. Global Paclitaxel Sales (Kg) Forecast by Region (2021-2026)
Table 14. Global Paclitaxel Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Paclitaxel Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Paclitaxel Revenue Share Forecast by Region (2021-2026)
Table 17. Global Paclitaxel (Kg) of Key Companies (2015-2020)
Table 18. Global Paclitaxel Sales Share by Company (2015-2020)
Table 19. Global Paclitaxel Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Paclitaxel Revenue Share by Company (2015-2020)
Table 21. Global Paclitaxel by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Paclitaxel as of 2019)
Table 22. Global Paclitaxel Average Price (USD/Kg) of Key Company (2015-2020)
Table 23. Manufacturers Paclitaxel Manufacturing Sites and Area Served
Table 24. Manufacturers Paclitaxel Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Paclitaxel Players
Table 27. Global Paclitaxel Sales (Kg) by Type (2015-2020)
Table 28. Global Paclitaxel Sales Share by Type (2015-2020)
Table 29. Global Paclitaxel Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Paclitaxel Price (Kg) by Type (2015-2020)
Table 31. Global Paclitaxel Sales Share by Type (2021-2026)
Table 32. Global Paclitaxel Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Paclitaxel Revenue Share by Type (2021-2026)
Table 34. Global Paclitaxel Price (Kg) by Type (2021-2026)
Table 35. Global Paclitaxel Sales (Kg) by Application (2015-2020)
Table 36. Global Paclitaxel Sales Share by Application (2015-2020)
Table 37. Global Paclitaxel Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Paclitaxel Price (Kg) by Application (2015-2020)
Table 39. Global Paclitaxel Sales (Kg) by Application (2021-2026)
Table 40. Global Paclitaxel Sales Share by Application (2021-2026)
Table 41. Global Paclitaxel Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Paclitaxel Revenue Share by Application (2021-2026)
Table 43. Global Paclitaxel Price (Kg) by Application (2021-2026)
Table 44. United States Paclitaxel Sales (Kg) by Company (2015-2020)
Table 45. United States Paclitaxel Sales Market Share by Company (2015-2020)
Table 46. United States Paclitaxel Sales (Kg) by Type (2015-2020)
Table 47. United States Paclitaxel Sales Market Share by Type (2015-2020)
Table 48. United States Paclitaxel Sales (Kg) by Application (2015-2020)
Table 49. United States Paclitaxel Sales Market Share by Application (2015-2020)
Table 50. Europe Paclitaxel Sales (Kg) by Company (2015-2020)
Table 51. Europe Paclitaxel Sales Market Share by Company (2015-2020)
Table 52. Europe Paclitaxel Sales (Kg) by Type (2015-2020)
Table 53. Europe Paclitaxel Sales Market Share by Type (2015-2020)
Table 54. Europe Paclitaxel Sales (Kg) by Application (2015-2020)
Table 55. Europe Paclitaxel Sales Market Share by Type (2015-2020)
Table 56. China Paclitaxel Sales (Kg) by Company (2015-2020)
Table 57. China Paclitaxel Sales Market Share by Company (2015-2020)
Table 58. China Paclitaxel Sales (Kg) by Type (2015-2020)
Table 59. China Paclitaxel Sales Market Share by Type (2015-2020)
Table 60. China Paclitaxel Sales (Kg) by Application (2015-2020)
Table 61. China Paclitaxel Sales Market Share by Application (2015-2020)
Table 62. Japan Paclitaxel Sales (Kg) by Company (2015-2020)
Table 63. Japan Paclitaxel Sales Market Share by Company (2015-2020)
Table 64. Japan Paclitaxel Sales (Kg) by Type (2015-2020)
Table 65. Japan Paclitaxel Sales Market Share by Type (2015-2020)
Table 66. Japan Paclitaxel Sales (Kg) by Application (2015-2020)
Table 67. Japan Paclitaxel Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Paclitaxel Sales (Kg) by Company (2015-2020)
Table 69. Southeast Asia Paclitaxel Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Paclitaxel Sales (Kg) by Type (2015-2020)
Table 71. Southeast Asia Paclitaxel Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Paclitaxel Sales (Kg) by Type (2015-2020)
Table 73. Southeast Asia Paclitaxel Sales Market Share by Application (2015-2020)
Table 74. India Paclitaxel Sales (Kg) by Company (2015-2020)
Table 75. India Paclitaxel Sales Market Share by Company (2015-2020)
Table 76. India Paclitaxel Sales (Kg) by Type (2015-2020)
Table 77. India Paclitaxel Sales Market Share by Type (2015-2020)
Table 78. India Paclitaxel Sales (Kg) by Application (2015-2020)
Table 79. India Paclitaxel Sales Market Share by Application (2015-2020)
Table 80. Phyton Corporation Information
Table 81. Phyton Description and Business Overview
Table 82. Phyton Paclitaxel Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 83. Phyton Paclitaxel Product
Table 84. Phyton Recent Development
Table 85. ScinoPharm Corporation Information
Table 86. ScinoPharm Description and Business Overview
Table 87. ScinoPharm Paclitaxel Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 88. ScinoPharm Paclitaxel Product
Table 89. ScinoPharm Recent Development
Table 90. Novasep Corporation Information
Table 91. Novasep Description and Business Overview
Table 92. Novasep Paclitaxel Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 93. Novasep Paclitaxel Product
Table 94. Novasep Recent Development
Table 95. Samyang Corporation Information
Table 96. Samyang Description and Business Overview
Table 97. Samyang Paclitaxel Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 98. Samyang Paclitaxel Product
Table 99. Samyang Recent Development
Table 100. Polymed Corporation Information
Table 101. Polymed Description and Business Overview
Table 102. Polymed Paclitaxel Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 103. Polymed Paclitaxel Product
Table 104. Polymed Recent Development
Table 105. TAPI (Teva) Corporation Information
Table 106. TAPI (Teva) Description and Business Overview
Table 107. TAPI (Teva) Paclitaxel Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 108. TAPI (Teva) Paclitaxel Product
Table 109. TAPI (Teva) Recent Development
Table 110. Fresenius-kabi Corporation Information
Table 111. Fresenius-kabi Description and Business Overview
Table 112. Fresenius-kabi Paclitaxel Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 113. Fresenius-kabi Paclitaxel Product
Table 114. Fresenius-kabi Recent Development
Table 115. Huiang biopharma Corporation Information
Table 116. Huiang biopharma Paclitaxel Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 117. Huiang biopharma Description and Business Overview
Table 118. Huiang biopharma Paclitaxel Product
Table 119. Huiang biopharma Recent Development
Table 120. Southpharma Corporation Information
Table 121. Southpharma Paclitaxel Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 122. Southpharma Description and Business Overview
Table 123. Southpharma Paclitaxel Product
Table 124. Southpharma Recent Development
Table 125. Yunnan Hande Corporation Information
Table 126. Yunnan Hande Description and Business Overview
Table 127. Yunnan Hande Paclitaxel Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 128. Yunnan Hande Paclitaxel Product
Table 129. Yunnan Hande Recent Development
Table 130. Hainan Yew Pharm Corporation Information
Table 131. Hainan Yew Pharm Description and Business Overview
Table 132. Hainan Yew Pharm Paclitaxel Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 133. Hainan Yew Pharm Paclitaxel Product
Table 134. Hainan Yew Pharm Recent Development
Table . Jiangsu Yew Biotechnology Corporation Information
Table . Jiangsu Yew Biotechnology Description and Business Overview
Table . Jiangsu Yew Biotechnology Paclitaxel Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table . Jiangsu Yew Biotechnology Paclitaxel Product
Table . Jiangsu Yew Biotechnology Recent Development
Table 140. Production Base and Market Concentration Rate of Raw Material
Table 141. Key Suppliers of Raw Materials
Table 142. Paclitaxel Distributors List
Table 143. Paclitaxel Customers List
Table 144. Market Key Trends
Table 145. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 146. Key Challenges
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Paclitaxel Product Picture
Figure 2. Global Paclitaxel Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Paclitaxel Market Share by Application in 2020 & 2026
Figure 6. Ovarian Cancer Examples
Figure 7. Cervical Cancer Examples
Figure 8. Breast Cancer Examples
Figure 9. Other Examples
Figure 10. Global Paclitaxel Sales (Kg) Growth Rate (2015-2026)
Figure 11. Global Paclitaxel Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Paclitaxel Price Trends Growth Rate (2015-2026) (USD/Kg)
Figure 13. Global Paclitaxel Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Paclitaxel Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Paclitaxel Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Paclitaxel Sales (Kg) Growth Rate (2015-2026)
Figure 17. Europe Paclitaxel Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Paclitaxel Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Paclitaxel Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Paclitaxel Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Paclitaxel Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Paclitaxel Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Paclitaxel Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Paclitaxel Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Paclitaxel Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Paclitaxel Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Paclitaxel Players Market Share by Revenue in Paclitaxel 2015 & 2019
Figure 28. Paclitaxel Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Paclitaxel Revenue Share by Type (2015-2020)
Figure 30. Global Paclitaxel Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Paclitaxel Revenue Share by Application (2015-2020)
Figure 32. Global Paclitaxel Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Paclitaxel Sales Market Share by Type in 2019
Figure 34. United States Paclitaxel Sales Market Share by Type in 2019
Figure 35. Europe Paclitaxel Sales Market Share by Company in 2019
Figure 36. Europe Paclitaxel Sales Market Share by Type in 2019
Figure 37. Europe Paclitaxel Sales Market Share by Application in 2019
Figure 38. China Paclitaxel Sales Market Share by Company in 2019
Figure 39. China Paclitaxel Sales Market Share by Type in 2019
Figure 40. China Paclitaxel Sales Market Share by Application in 2019
Figure 41. Japan Paclitaxel Sales Market Share by Company in 2019
Figure 42. Japan Paclitaxel Sales Market Share by Type in 2019
Figure 43. Japan Paclitaxel Sales Market Share by Application in 2019
Figure 44. Southeast Asia Paclitaxel Sales Market Share by Company in 2019
Figure 45. Southeast Asia Paclitaxel Sales Market Share by Type in 2019
Figure 46. Southeast Asia Paclitaxel Sales Market Share by Application in 2019
Figure 47. India Paclitaxel Sales Market Share by Company in 2019
Figure 48. India Paclitaxel Sales Market Share by Type in 2019
Figure 49. India Paclitaxel Sales Market Share by Application in 2019
Figure 50. Phyton Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. ScinoPharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Novasep Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Samyang Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Polymed Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. TAPI (Teva) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Fresenius-kabi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Huiang biopharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Southpharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Yunnan Hande Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Hainan Yew Pharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Jiangsu Yew Biotechnology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Key Raw Materials Price Trend
Figure 63. Manufacturing Cost Structure of Paclitaxel
Figure 64. Manufacturing Process Analysis of Paclitaxel
Figure 65. Paclitaxel Industrial Chain Analysis
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Figure 68. Porter's Five Forces Analysis
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
パクリタキセル注射の世界市場レポート2020 A recently published report by QY Research titled Global Paclitaxel Injection Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accura…- 子宮頸がん診断検査装置の世界市場レポート2020 Market Analysis and Insights: Global Cervical Cancer Diagnostic Testing Devices Market The global Cervical Cancer Diagnostic Testing Devices market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Cervical Cancer…
- 卵巣がんの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Ovarian Cancer market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 9.0% in the forecast period of 2020 to 2025 and will expected to reach USD 2382 million by 2025, from USD 1684.4 million in 2019. The Ovarian Cancer market r…
- 卵巣がん治療薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Ovarian Cancer Treatment Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Ovarian Cancer…
- 子宮頸がん治療薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Cervical Cancer Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.2% in the forecast period of 2020 to 2025 and will expected to reach USD 14770 million by 2025, from USD 13550 million in 2019. The Cervical Cancer …